The 12th Five -Year Plan of the Biomedical Industry will announce the direction of the main new drug
Release time: 2011-06-28 & nbsp & nbsp & nbsp Source:
Business Club, June 24. Biomedical as an important part of the biological industry，It will become one of the strategic emerging pillar industries for my country's rapid development。
Reporter learned a few days ago，The "Twelfth Five -Year Plan" drafted by the National Development and Reform Commission drafted by the National Development and Reform Commission has recently been introduced。to 2015，my country's biomedical market is expected to reach 100 billion US dollars，The output value of the pharmaceutical and biotechnology industry reaches 200 billion yuan。
At the 5th Biological Industry Conference held a few days ago，Director of the Institute of Industry, Technical and Economics, Macro Research and Research Institute of the National Development and Reform Commission、"Twelfth Five -Year Plan" planning group leader Wang Changlin introduced，In the next five years，The development of biomedicine will mainly emphasize biotechnology and drugs used for major disease prevention and control、New vaccine、Diagnostic reagent、Chemical drugs and other innovative drugs。"Strive until 2015，The sales revenue of the top 100 new drug companies accounts for 50%of the total sales revenue of the industry，By 2020，5 companies enter the top 100 medical medicine。”
"Twelfth Five -Year" period，my country's biomedical industry strives to break through from a pharmaceutical country to a pharmaceutical power。
Wang Changlin said，The biomedical industry maintains a growth rate of 20%. There is no problem，The core question is how to strengthen，We are already a big country in the pharmaceutical industry。How to develop a heavy new medicine with independent intellectual property rights、Accelerate the industrialization of major technologies and improve the level of internationalization of biomedicine in my country as soon as possible，Is the focus of the future。
Director Qiu Hongwei of the Policy Office of China Biotechnology Development Center said，At present, my country's biomedical industry has grown rapidly and has begun to take shape，But the size of the enterprise is small、Weak technical innovation ability。Among the top ten biotechnology products in the international market in recent years，No products in our country。About 30,000 major scientific and technological achievements obtained each year in stake sports betting appmy stake sports betting appcountry，The average conversion rate is only 20%，Realization of industrialization is less than 5%; the transformation rate of scientific and technological achievements in universities is less than 10%，and the transformation rate of the achievements of pharmaceutical technology is less than 8%。
"Planning" formulated a grand goal: "Twelfth Five -Year Plan" period，Obtain more than 200 clinical approval of new drugs，New drug certificate、Veterinary Drug Certificate、More than 100 certificates such as medical device certificates。
According to disclosure，Relevant departments also formulated the "major new drug creation policy" supporting "planning"，Clear key support direction，Including major new drug creation、Cultivation of new genetically modified biological varieties、Prevention and treatment of major infectious diseases such as AIDS and viral hepatitis、Research and Development of vaccine and antibody products、Development of major products in vitro diagnosis、Digital medical and biomedical materials。
Sang Guowei, vice chairman of the Standing Committee of the National People's Congress, recently depicts the overall goal of creating the major new drug creation of the "Twelfth Five -Year Plan" recently: "New drugs more、Big medicine greater、Platform internationalization、Breakthrough key technology、Cultivate large enterprises。”
The biological industry 12th Five -Year Plan sets 2 trillion cakes to be divided
Reporter learned at the Chinese Biological Industry Conference held in Shenzhen a few days ago，The "Twelfth Five -Year Plan" drafted by the National Development and Reform Commission entered the final demonstration stage，Its basic framework has been formed。
"Relevant departments are jointly compiling the" Planning of the Biological Industry Development "125" Plan "，To further strengthen the capacity of the biological industry's independent innovation capabilities，Promoting the industrialization of biotechnology、Clusterization and international development，Make it an important pillar industry for the new economic and social development of my country。"Zhang Xiaoqiang, deputy director of the National Development and Reform Commission, told the" Economic Reference News "reporter。
According to disclosure，In the future, my country's biological industry will focus on the development of biomedicine、Biological Agriculture、Biological Energy、Biological Environmental Protection、Biological service outsourcing five major aspects; the national biological industry output value reached 4 trillion yuan in 2015，reached 8 trillion to 10 trillion yuan from 2020。
According to industry experts，Development of biomedical，In the next five years, it will mainly emphasize biotechnology drugs used for major disease prevention and control、New vaccine、Diagnostic reagent、Chemical drugs and other innovative drugs。"By 2015，The sales revenue of the top 100 new drug companies will account for 50%of the total sales revenue of the industry; by 2020，5 companies enter the top 100 medical medicine。"Wang Changlin, Director of the Institute of Industry, Technology and Economics, Macro Research and Reform Institute of the National Development and Reform Commission, said。
It is reported，In the "Twelfth Five -Year Plan" of the Biological Industry Development，Biochemical breeding will Stake Sports Bettingrise stake sports betting appto an important location。This means that "planning" is introduced，GM research in the biological field will enter the rapid development period.，It is much larger than "115"。"Relevant persons told reporters。
According to disclosure，As of the end of last year，Including the central financial investment、Local financial investment、Enterprise supporting investment is inside，The central government implements a special investment scale of genetically modified genes reached 26 billion yuan，and the "Twelfth Five -Year Plan" period will continue to increase strength。In addition，According to experts from the National Development and Reform Commission，In the next five years，In terms of biological manufacturing，Biological products account for more than 10%of petrochemical products; in terms of biological agriculture，Cultivate 200 new varieties of animals and plants; in terms of biological energy，The proportion of non -grain raw materials increased。
For the development path of the biological industry，Wang Changlin said，In the next 5 to 10 years，my country's biological industry will develop from technology、Industrialization、Industry upgrade、State cooperation and other aspects，Gradually form a biological industry system。
"The development of the biological industry must form a fiscal and tax support system，To subsidize the government procurement of biological products，To increase consumption tax to relevant products，Support biological products to support biological products。"The Chinese Academy of Sciences Ma Yanhe said。
Wang Changlin said，Currently, countries around the world have accelerated the cultivation of new economic growth points，Repeat the economy after the financial crisis is re -prepared，The biological industry has become an important choice for many countries。Data display，Global biological industry sales turn over almost every 5 years，The growth rate is nearly 10 times the average growth rate of the world economy。It is expected to be 2020，Biomedical proportion of global drugs will exceed 1/3，Biomass energy accounts for about 5%of the world's energy consumption，Bio -based materials will replace 10%to 20%chemical materials，The biological law manufacturing of fine chemicals will replace 30%to 60%of the chemical method。
In recent years，my country takes a series of measures to increase support for biotechnology innovation and the development of the biological industry，Including the introduction of the "Eleventh Five -Year Plan of the Biological Industry Development"，Organize the industrialization of biotechnology innovation achievements and strengthen the construction of national biological industry bases。In June 2009, the General Office of the State Council issued the "Several Policies to Promote the Accelerated Development of the Biological Industry"，It is clearly proposed to accelerate the cultivation of the biological industry into a high -tech pillar industry and the country's strategic emerging industry "Eleventh Five -Year Plan"，my country's biotechnology enters the stage of large -scale industrialization，and start entering the industrial stake betting appprofit stake betting appperiod。2010，my country's biological industry growth rate is 20%，Become a high -anti -risk industry in the financial crisis。
Advantages of the agglomeration
The biological industry is a key field of strategic emerging industries at this stage，"Eleventh Five -Year Plan" period，The output value of the biological industry has jumped from 600 billion yuan to 1600 billion yuan，The average annual growth rate of 21.6%。Wang Changlin, Director of the Institute of Industrial Economy, Technology and Economics of the National Development and Reform Commission, pointed out，In the next five years, my country will focus on developing biomedicine、Biological Agriculture、Biological Energy、Biological Environmental Protection、Several aspects of biological manufacturing and biological services。
Some experts said，The advantages of the agglomeration and development of the domestic biological industry in the future will appear。Current，The agglomeration effect of the development of the domestic biological industry is obvious，Since the National Development and Reform Commission in 2005, the National Development and Reform Commission began to identify the first batch of national biological industry bases，Beijing、Shanghai、Shenzhen、Tianjin、Guangzhou、Harbin、Shijiazhuang、Jinan、Qingdao、Tonghua and other places have found nearly a hundred biological base parks，The linkage development of the biological industry in the park is great。
"Twelfth Five -Year" period，The biological industry base will further promote industrial growth。Take Shijiazhuang National Biological Industry Base as an example，The focus of development will include the six major development aspects of the biological industry，and will vigorously realize the internationalization of biomedicine，Actively cultivate the medical device industry，Enhancement in biological breeding、R & D control of biotechnology control biotechnology。The base completed the main income of 47 billion yuan in 2010，Realizing profit and tax 7 billion yuan。In addition，Guangzhou National Biological Industry Base、Nanchang's national high -tech industrial base、Qingdao National Biological Industry Base and other base parks have set up development goals，Give play to the role of radiation，Gradually cultivate the biological industry into a regional leading industry。
Fund support and technical flow accelerate
Relevant experts point out，The "Twelfth Five -Year Plan" period of the biological industry will get more solid capital support。Current，"Twelfth Five -Year Plan" Plan for Biological Industry Development "has absorbed the systemic financing plan of some banks。
Li Jiping, vice president of National Development Bank, said，The credit policy will be continuously improved in the future，Rich "Vote、Loan、Debt、Rent、Certificate "combination product service system and function，To better support the development of the biological industry。According to an introduction，From 2007 to 2010, the average annual growth rate of the biological industry loan of the State Development Bank reached 56.1%，Focus on Beijing、Wuhan、Changsha、Shanghai、Taizhou、Construction of biological industry bases such as Benxi。The development prospects of the biological industry are increasingly optimistic。
In addition，Local governments have stake betting appbegun My stake betting appto accelerate the exploration of new measures for biological enterprises。Current，Biological Resources province Yunnan has set out to set up biological (pharmaceutical) industrial entrepreneurial investment funds and industrial funds，To solve the insufficient research and development funds of new drugs in biomedical companies、It is difficult to raise funds in the early days of technical industrialization。
and the industry is more optimistic about the technical flow and international cooperation prospects during the "Twelfth Five -Year Plan" period of the biological industry。Li Jinju, Drug Registration Department of the State Food and Drug Administration, thinks，At present, the Chinese government attaches great importance to medical innovation，great progress in the protection of intellectual property，Basic improvement of infrastructure construction in the pharmaceutical industry，Division of labor is increasingly complete，And rich human resources，These aspects gradually become a favorable factor for biomedical research and development into China。David Wilkinson, Global Director of Astraika，China's biotechnology platform is providing support for international cooperation and technology transfer，China is the most potential emerging pharmaceutical market in the world，In the next few years，The share of emerging markets will account for more than 50%of global growth，Therefore, the cooperation with China in biomedical is imperative。
Current，Beijing、Wuhan、Tianjin、International cooperation in the biological industry in Guangzhou and other places is constantly accelerating。The plant genetic renovation project of the American Academy of Sciences landed in Wuhan Optical Valley Biological City，Roche、Nova、GE、Astrikan、Sanofian Wande and other companies have also begun to negotiate cooperation with domestic biological enterprises。
Reporter learned a few days ago，The "Twelfth Five -Year Plan" drafted by the National Development and Reform Commission drafted by the National Development and Reform Commission has recently been introduced。to 2015，my country's biomedical market is expected to reach 100 billion US dollars，The output value of the pharmaceutical and biotechnology industry reaches 200 billion yuan。
At the 5th Biological Industry Conference held a few days ago，Director of the Institute of Industry, Technical and Economics, Macro Research and Research Institute of the National Development and Reform Commission、"Twelfth Five -Year Plan" planning group leader Wang Changlin introduced，In the next five years，The development of biomedicine will mainly emphasize biotechnology and drugs used for major disease prevention and control、New vaccine、Diagnostic reagent、Chemical drugs and other innovative drugs。"Strive until 2015，The sales revenue of the top 100 new drug companies accounts for 50%of the total sales revenue of the industry，By 2020，5 companies enter the top 100 medical medicine。”
"Twelfth Five -Year" period，my country's biomedical industry strives to break through from a pharmaceutical country to a pharmaceutical power。
Wang Changlin said，The biomedical industry maintains a growth rate of 20%. There is no problem，The core question is how to strengthen，We are already a big country in the pharmaceutical industry。How to develop a heavy new medicine with independent intellectual property rights、Accelerate the industrialization of major technologies and improve the level of internationalization of biomedicine in my country as soon as possible，Is the focus of the future。
Director Qiu Hongwei of the Policy Office of China Biotechnology Development Center said，At present, my country's biomedical industry has grown rapidly and has begun to take shape，But the size of the enterprise is small、Weak technical innovation ability。Among the top ten biotechnology products in the international market in recent years，No products in our country。About 30,000 major scientific and technological achievements obtained each year in stake sports betting appmy stake sports betting appcountry，The average conversion rate is only 20%，Realization of industrialization is less than 5%; the transformation rate of scientific and technological achievements in universities is less than 10%，and the transformation rate of the achievements of pharmaceutical technology is less than 8%。
"Planning" formulated a grand goal: "Twelfth Five -Year Plan" period，Obtain more than 200 clinical approval of new drugs，New drug certificate、Veterinary Drug Certificate、More than 100 certificates such as medical device certificates。
According to disclosure，Relevant departments also formulated the "major new drug creation policy" supporting "planning"，Clear key support direction，Including major new drug creation、Cultivation of new genetically modified biological varieties、Prevention and treatment of major infectious diseases such as AIDS and viral hepatitis、Research and Development of vaccine and antibody products、Development of major products in vitro diagnosis、Digital medical and biomedical materials。
Sang Guowei, vice chairman of the Standing Committee of the National People's Congress, recently depicts the overall goal of creating the major new drug creation of the "Twelfth Five -Year Plan" recently: "New drugs more、Big medicine greater、Platform internationalization、Breakthrough key technology、Cultivate large enterprises。”
The biological industry 12th Five -Year Plan sets 2 trillion cakes to be divided
Reporter learned at the Chinese Biological Industry Conference held in Shenzhen a few days ago，The "Twelfth Five -Year Plan" drafted by the National Development and Reform Commission entered the final demonstration stage，Its basic framework has been formed。
"Relevant departments are jointly compiling the" Planning of the Biological Industry Development "125" Plan "，To further strengthen the capacity of the biological industry's independent innovation capabilities，Promoting the industrialization of biotechnology、Clusterization and international development，Make it an important pillar industry for the new economic and social development of my country。"Zhang Xiaoqiang, deputy director of the National Development and Reform Commission, told the" Economic Reference News "reporter。
According to disclosure，In the future, my country's biological industry will focus on the development of biomedicine、Biological Agriculture、Biological Energy、Biological Environmental Protection、Biological service outsourcing five major aspects; the national biological industry output value reached 4 trillion yuan in 2015，reached 8 trillion to 10 trillion yuan from 2020。
According to industry experts，Development of biomedical，In the next five years, it will mainly emphasize biotechnology drugs used for major disease prevention and control、New vaccine、Diagnostic reagent、Chemical drugs and other innovative drugs。"By 2015，The sales revenue of the top 100 new drug companies will account for 50%of the total sales revenue of the industry; by 2020，5 companies enter the top 100 medical medicine。"Wang Changlin, Director of the Institute of Industry, Technology and Economics, Macro Research and Reform Institute of the National Development and Reform Commission, said。
It is reported，In the "Twelfth Five -Year Plan" of the Biological Industry Development，Biochemical breeding will Stake Sports Bettingrise stake sports betting appto an important location。This means that "planning" is introduced，GM research in the biological field will enter the rapid development period.，It is much larger than "115"。"Relevant persons told reporters。
According to disclosure，As of the end of last year，Including the central financial investment、Local financial investment、Enterprise supporting investment is inside，The central government implements a special investment scale of genetically modified genes reached 26 billion yuan，and the "Twelfth Five -Year Plan" period will continue to increase strength。In addition，According to experts from the National Development and Reform Commission，In the next five years，In terms of biological manufacturing，Biological products account for more than 10%of petrochemical products; in terms of biological agriculture，Cultivate 200 new varieties of animals and plants; in terms of biological energy，The proportion of non -grain raw materials increased。
For the development path of the biological industry，Wang Changlin said，In the next 5 to 10 years，my country's biological industry will develop from technology、Industrialization、Industry upgrade、State cooperation and other aspects，Gradually form a biological industry system。
"The development of the biological industry must form a fiscal and tax support system，To subsidize the government procurement of biological products，To increase consumption tax to relevant products，Support biological products to support biological products。"The Chinese Academy of Sciences Ma Yanhe said。
Wang Changlin said，Currently, countries around the world have accelerated the cultivation of new economic growth points，Repeat the economy after the financial crisis is re -prepared，The biological industry has become an important choice for many countries。Data display，Global biological industry sales turn over almost every 5 years，The growth rate is nearly 10 times the average growth rate of the world economy。It is expected to be 2020，Biomedical proportion of global drugs will exceed 1/3，Biomass energy accounts for about 5%of the world's energy consumption，Bio -based materials will replace 10%to 20%chemical materials，The biological law manufacturing of fine chemicals will replace 30%to 60%of the chemical method。
In recent years，my country takes a series of measures to increase support for biotechnology innovation and the development of the biological industry，Including the introduction of the "Eleventh Five -Year Plan of the Biological Industry Development"，Organize the industrialization of biotechnology innovation achievements and strengthen the construction of national biological industry bases。In June 2009, the General Office of the State Council issued the "Several Policies to Promote the Accelerated Development of the Biological Industry"，It is clearly proposed to accelerate the cultivation of the biological industry into a high -tech pillar industry and the country's strategic emerging industry "Eleventh Five -Year Plan"，my country's biotechnology enters the stage of large -scale industrialization，and start entering the industrial stake betting appprofit stake betting appperiod。2010，my country's biological industry growth rate is 20%，Become a high -anti -risk industry in the financial crisis。
Advantages of the agglomeration
The biological industry is a key field of strategic emerging industries at this stage，"Eleventh Five -Year Plan" period，The output value of the biological industry has jumped from 600 billion yuan to 1600 billion yuan，The average annual growth rate of 21.6%。Wang Changlin, Director of the Institute of Industrial Economy, Technology and Economics of the National Development and Reform Commission, pointed out，In the next five years, my country will focus on developing biomedicine、Biological Agriculture、Biological Energy、Biological Environmental Protection、Several aspects of biological manufacturing and biological services。
Some experts said，The advantages of the agglomeration and development of the domestic biological industry in the future will appear。Current，The agglomeration effect of the development of the domestic biological industry is obvious，Since the National Development and Reform Commission in 2005, the National Development and Reform Commission began to identify the first batch of national biological industry bases，Beijing、Shanghai、Shenzhen、Tianjin、Guangzhou、Harbin、Shijiazhuang、Jinan、Qingdao、Tonghua and other places have found nearly a hundred biological base parks，The linkage development of the biological industry in the park is great。
"Twelfth Five -Year" period，The biological industry base will further promote industrial growth。Take Shijiazhuang National Biological Industry Base as an example，The focus of development will include the six major development aspects of the biological industry，and will vigorously realize the internationalization of biomedicine，Actively cultivate the medical device industry，Enhancement in biological breeding、R & D control of biotechnology control biotechnology。The base completed the main income of 47 billion yuan in 2010，Realizing profit and tax 7 billion yuan。In addition，Guangzhou National Biological Industry Base、Nanchang's national high -tech industrial base、Qingdao National Biological Industry Base and other base parks have set up development goals，Give play to the role of radiation，Gradually cultivate the biological industry into a regional leading industry。
Fund support and technical flow accelerate
Relevant experts point out，The "Twelfth Five -Year Plan" period of the biological industry will get more solid capital support。Current，"Twelfth Five -Year Plan" Plan for Biological Industry Development "has absorbed the systemic financing plan of some banks。
Li Jiping, vice president of National Development Bank, said，The credit policy will be continuously improved in the future，Rich "Vote、Loan、Debt、Rent、Certificate "combination product service system and function，To better support the development of the biological industry。According to an introduction，From 2007 to 2010, the average annual growth rate of the biological industry loan of the State Development Bank reached 56.1%，Focus on Beijing、Wuhan、Changsha、Shanghai、Taizhou、Construction of biological industry bases such as Benxi。The development prospects of the biological industry are increasingly optimistic。
In addition，Local governments have stake betting appbegun My stake betting appto accelerate the exploration of new measures for biological enterprises。Current，Biological Resources province Yunnan has set out to set up biological (pharmaceutical) industrial entrepreneurial investment funds and industrial funds，To solve the insufficient research and development funds of new drugs in biomedical companies、It is difficult to raise funds in the early days of technical industrialization。
and the industry is more optimistic about the technical flow and international cooperation prospects during the "Twelfth Five -Year Plan" period of the biological industry。Li Jinju, Drug Registration Department of the State Food and Drug Administration, thinks，At present, the Chinese government attaches great importance to medical innovation，great progress in the protection of intellectual property，Basic improvement of infrastructure construction in the pharmaceutical industry，Division of labor is increasingly complete，And rich human resources，These aspects gradually become a favorable factor for biomedical research and development into China。David Wilkinson, Global Director of Astraika，China's biotechnology platform is providing support for international cooperation and technology transfer，China is the most potential emerging pharmaceutical market in the world，In the next few years，The share of emerging markets will account for more than 50%of global growth，Therefore, the cooperation with China in biomedical is imperative。
Current，Beijing、Wuhan、Tianjin、International cooperation in the biological industry in Guangzhou and other places is constantly accelerating。The plant genetic renovation project of the American Academy of Sciences landed in Wuhan Optical Valley Biological City，Roche、Nova、GE、Astrikan、Sanofian Wande and other companies have also begun to negotiate cooperation with domestic biological enterprises。
